<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2014020316473N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2014-02-26</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Effects of adding Braun jejunojejunostomy to standard Whipple procedure on reduction of afferent loop syndrome- A Randomized control clinical trial .</public_title>
      <acronym>Braun jejunojejunostomy</acronym>
      <scientific_title>Effects of adding Braun jejunojejunostomy to standard Whipple procedure on reduction of afferent loop syndrome- A Randomized control clinical trial .</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2013-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/15408</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Malignant neoplasm: Head of pancreas. Condition 2: Malignant neoplasm: Ampulla of Vater.</hc_freetext>
      <i_freetext>Intervention 1: The control group will be undergone the standard Whipple procedure. Two layer ductojejunostomy will be used for pancreaticojejunostomy anastomosis. Choledochojejunostomy will be done 5-10 centimeter distal to the pancreaticojejunostomy in 1 layer by 4-0 PDS separate sutures and the gastrojejunostomy will be done in ante colic manner 30-45 centimeter distal to the previous anastomosis.   At the end of the procedure, two corrugate drain will be inserted in the liver bed and pancreatic bed in the right and left side respectively. Intervention 2: The intervention group will be undergone the standard Whipple procedure plus Braun jejunojejunostomy. Two layer ductojejunostomy will be used for pancreaticojejunostomy anastomosis. Choledochojejunostomy will be done 5-10 centimeter distal to the pancreaticojejunostomy in 1 layer by 4-0 PDS separate sutures and the gastrojejunostomy will be done in ante colic manner 30-45 centimeter distal to the previous anastomosis.   Braun jejunojejunostomy will be done in 2 layer by PDS 2-0 in standard manner, the distance between the anastomosis and choledochojejunostomy anastomosis will be near 30 centimeter and the distal loop will be near 40 centimeter. At the end of the procedure, two corrugate drain will be inserted in the liver bed and pancreatic bed in the right and left side respectively.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farzad Kakaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Reza hospital</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 41 1334 1317</telephone>
        <email>fkakaei@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farzad Kakaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Reza hospital</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 41 1334 1317</telephone>
        <email>fkakaei@yahoo.com</email>
        <affiliation>Tabriz University of Medical Ssciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: age between 18-75 years; operability according to the preoperative imaging studies ( no invasion to portal vein, superior mesenteric artery or superior mesenteric vein, no distant metastasis, no invasion to adjacent organs); presence of pancreatic head,or duodenal, or common bile duct tumor which needs Whipple procedure &#13;
               Exclusion criteria: age over 75 or less than 18; death during the operation; inoperability according to any intraoperative findings</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C25.0</hc_code>
      <hc_code>C24.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malignant neoplasm: Head of pancreas</hc_keyword>
      <hc_keyword>Malignant neoplasm: Ampulla of Vater</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The control group will be undergone the standard Whipple procedure. Two layer ductojejunostomy will be used for pancreaticojejunostomy anastomosis. Choledochojejunostomy will be done 5-10 centimeter distal to the pancreaticojejunostomy in 1 layer by 4-0 PDS separate sutures and the gastrojejunostomy will be done in ante colic manner 30-45 centimeter distal to the previous anastomosis.   At the end of the procedure, two corrugate drain will be inserted in the liver bed and pancreatic bed in the right and left side respectively.</i_keyword>
      <i_keyword>The intervention group will be undergone the standard Whipple procedure plus Braun jejunojejunostomy. Two layer ductojejunostomy will be used for pancreaticojejunostomy anastomosis. Choledochojejunostomy will be done 5-10 centimeter distal to the pancreaticojejunostomy in 1 layer by 4-0 PDS separate sutures and the gastrojejunostomy will be done in ante colic manner 30-45 centimeter distal to the previous anastomosis.   Braun jejunojejunostomy will be done in 2 layer by PDS 2-0 in standard manner, the distance between the anastomosis and choledochojejunostomy anastomosis will be near 30 centimeter and the distal loop will be near 40 centimeter. At the end of the procedure, two corrugate drain will be inserted in the liver bed and pancreatic bed in the right and left side respectively.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Afferent loop syndrome. Timepoint: during the hospital stay after the thirdth day after the operation. Method of measurement: Questinaire (sudden bulky bile stained vomitus without any relation to eating).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Postoperative death. Timepoint: during the total hospital stay. Method of measurement: questionnaire.</sec_outcome>
      <sec_outcome>Pancreatic anastomosis leakage. Timepoint: daily till discharge. Method of measurement: questionnaire (high amylase drainage from drains).</sec_outcome>
      <sec_outcome>Gastric anastomosis leakage. Timepoint: daily till discharge. Method of measurement: questionnaire (low pH drainage from drains).</sec_outcome>
      <sec_outcome>Biliary anastomosis leakage. Timepoint: daily till discharge. Method of measurement: questionnaire (high bilirubin drainage from drains).</sec_outcome>
      <sec_outcome>Postoperative bleeding which needs another operation. Timepoint: daily till discharge. Method of measurement: questionnaire.</sec_outcome>
      <sec_outcome>Postoperative gastrointestinal bleeding which needs repeat operation. Timepoint: daily till discharge. Method of measurement: questionnaire.</sec_outcome>
      <sec_outcome>Surgical site infection. Timepoint: daily till discharge. Method of measurement: questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2013-09-30</approval_date>
        <contact_name>Tabriz University of Medical Sciences</contact_name>
        <contact_address>Golgasht Street Tabriz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
